GOLDSMITH MARK A bought RVMD
April 15, 2026 · Form 4 insider transaction
GOLDSMITH MARK A bought 96,756 shares of Revolution Medicines, Inc. at $4.73 per share, a transaction worth $457.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
96,756
Price
$4.73
Total value
$457.7K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 15, 2026
Filing dateApril 17, 2026
Shares owned after396,698
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 201,150 restricted stock units.